Concepedia

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes

Nicolae Mircea Panduru, Carol Forsblom, Markku Saraheimo, Lena M. Thorn, Angelika Bierhaus, Per M. Humpert, Per‐Henrik Groop

Diabetes Care · 2013 · 97 citations · 29 references

DOIFull text

Open access

Abstract

L-FABP is an independent predictor of progression of DN irrespective of disease stage. L-FABP used alone or together with AER may not improve the risk prediction of DN progression in patients with type 1 diabetes, but further studies are needed in this regard.

References

29

MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS

G C Viberti, R. J. Jarrett, U. Mahmud et al. · The Lancet · 1982 · 1.7K citations

, , +8

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

Lesley A. Stevens, Josef Coresh, Christopher H. Schmid et al. · American Journal of Kidney Diseases · 2008 · 1K citations · Full text

, , +10

The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

Per‐Henrik Groop, Merlin C. Thomas, John L. Moran et al. · Diabetes · 2009 · 629 citations · Full text

Metabolic Syndrome in Type 1 Diabetes

Lena M. Thorn, Carol Forsblom, Johan Fagerudd et al. · Diabetes Care · 2005 · 416 citations · Full text

Renal L-Type Fatty Acid–Binding Protein in Acute Ischemic Injury

Tokunori Yamamoto, Eisei Noiri, Yoshinari Ono et al. · Journal of the American Society of Nephrology · 2007 · 365 citations

, , +20